Overview

Study of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19

Status:
Terminated
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of merimepodib (MMPD) oral solution when administered in combination with remdesivir in adult patients with advanced COVID-19.
Phase:
Phase 2
Details
Lead Sponsor:
ViralClear Pharmaceuticals, Inc.
Treatments:
Remdesivir